ĀÜĄņĀŅĀ×

Monica Luchi joins Brickell with 20 years of experience in the biotech/pharmaceutical industry across all phases of clinical development, strategic planning and business development. Monica was most recently working as interim Chief Medical Officer and Clinical Development consultant for The Bracken Group.

Monica began her career in an academic practice focused on Rheumatology and Immunology before moving to the pharmaceutical industry. She has held positions of increasing responsibility at Novartis, Incyte, Mesoblast, Immune Pharmaceuticals, Celularity and Sorrento Pharmaceuticals in clinical development, translational medicine, and strategic planning, as well as key business development roles. Her experience ranges across all stages of development, from exploratory phase 1 through phase 3, in multiple therapeutic indications, and includes numerous regulatory filings.

Dr. Luchi earned a B.A, Biology, Health Sciences Policy from University of Maryland, an M.D. from Northeastern Ohio Universities, College of Medicine, an M.B.A from George Washington University and an Innovation and Entrepreneurship program certificate from Stanford University. Dr. Luchi is a practicing rheumatologist with an adjunct appointment at the University of Pennsylvania. She also serves on the Board of Trustees for the Childrenā€™s Village, NYC.